March 6 2008
SAREUM HOLDINGS PLC
(“Sareum” or “the Company”)
FINANCIAL RESULTS FOR THE SIX MONTHS ENDED 31 DECEMBER 2007
Sareum Holdings plc (AIM: SAR), the specialist structure-based drug discovery business, is pleased to announce its financial results for the six month period ended 31 December 2007.
Financial highlights during period 1 July to 31 December 2007:
Business highlights during period 1 July to 31 December 2007:
Post-period end highlights:
Dr Tim Mitchell, CEO of Sareum Holdings plc, said: “We believe shareholder value can be maximised from our in-house cancer programmes and are pleased to report a productive research period where we have significantly progressed our internal pipeline. Sareum has managed to maintain its level of fee for service work and we continue to focus on the development and commercialisation of our internal programmes.”
Sareum Holdings plc |
01223 497700 |
Tim Mitchell, Chief Executive Officer |
|
Buchanan Communications |
020 7466 5000 |
Tim Anderson, Mary-Jane Johnson |
|
Grant Thornton Corporate Finance |
020 7383 5100 |
Philip Secrett, Colin Aaronson |
|